| Literature DB >> 33477900 |
Peng-Zhou Hang1,2, Hua Zhu1, Pei-Feng Li2, Jie Liu2, Feng-Qin Ge1, Jing Zhao3, Zhi-Min Du2,4.
Abstract
Brain-derived neurotrophic factor (BDNF) is one of the most abundantneurotrophins in the central nervous system. Numerous studies suggestthat BDNF has extensive roles by binding to its specific receptor, tropomyosin-related kinase receptor B (TrkB), and thereby triggering downstream signaling pathways. Recently, growing evidence highlightsthat the BDNF/TrkB pathway is expressed in the cardiovascular system andclosely associated with the development and outcome of cardiovascular diseases (CVD), including coronary artery disease, heart failure, cardiomyopathy, hypertension, and metabolic diseases. Furthermore, circulating BDNF has also been revealed as a new potential biomarker for both diagnosis and prognosis of CVD. In this review, we discuss the current evidence of the emerging role of BDNF/TrkBsignalingand address the challenges that remain in translating these discoveries to novel therapeutic strategies for CVD.Entities:
Keywords: biomarker; brain-derived neurotrophic factor; cardiovascular diseases; tropomyosin-related kinase receptor B
Year: 2021 PMID: 33477900 PMCID: PMC7833389 DOI: 10.3390/life11010070
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729